Siglec-2/CD22 Antibody (MMAE)

SKU: orb1805460

Description

Anti-Siglec-2 / CD22 Reference Antibodyand Monomethyl auristatin E (MMAE) used for the study of hematological malignancies.

Images & Validation

−

Item 1 of 3

Tested Applications	ELISA, FA, FACS, In vivo
Reactivity	Human

Key Properties

−

Antibody Type	Recombinant Antibody
Clonality	Recombinant
Target	Siglec-2 / CD22
Source/Expression System	CHO
Molecular Weight	151.97 kDa
Purity	>95%
Purification	Protein A
Endotoxin	<0.001 EU/ug
Conjugation	MMAE

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Buffer/Preservatives	100 mM Proline/Acetic acid 20mM Arginine pH 5.0
Concentration	Batch dependent
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

The purity of Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)is more than 95% ;determined by SEC-HPLC.

Immobilized human Siglec 2 / CD22; His Tag at 2 μg/mL can bind Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin);EC50=0.008851μg/mL.

Quick Database Links

Gene Symbol

Siglec-2 / CD22

UniProt

P20273

UniProt Details

−

No UniProt data available

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

FACS

Fluorescence-Activated Cell Sorting (FC, Flow cytometry)

View Protocol

ELISA

Enzyme-linked Immunosorbent Assay (EIA)

View Protocol

Find More Protocols